Search research articles
Contact Us
Filters
Showing results (71-80 of 206) with videos related to
Page
of 21
Sort By:
International Journal of Clinical Practice
|
November 26, 2009
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
K G Parhofer, K I Birkeland, R DeFronzo, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
November 25, 2003
[Integrin Beta 3 PlA1/PlA2 polimorphism does not contribute to complications in both type 1 and type 2 diabetes]
L Pucci, D Lucchesi, C Fotino, et al.
Metabolism: Clinical and Experimental
|
June 1, 1981
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle
R Nosadini, K G Alberti, D G Johnston, et al.
European Journal of Clinical Investigation
|
January 5, 2000
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR)
S E Baldeweg, A Golay, A Natali, et al.
The Journal of Clinical Investigation
|
July 1, 1996
Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals
A Avogaro, G Toffolo, M Miola, et al.
Diabetes/Metabolism Reviews
|
September 1, 1995
Metformin and free fatty acid metabolism
S Del Prato, S Marchetto, A Pipitone, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1996
Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism
A Avogaro, A Valerio, M Miola, et al.
Metabolism: Clinical and Experimental
|
May 1, 1983
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects
A Avogaro, E Duner, C Marescotti, et al.
Expert Review of Clinical Pharmacology
|
April 23, 2017
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus
A Avogaro, A Giaccari, P Fioretto, et al.
Metabolism: Clinical and Experimental
|
May 1, 1990
Obesity and insulin resistance in humans: a dose-response study
R C Bonadonna, L Groop, N Kraemer, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 206) with videos related to
Sort By:
Page
of 21
International Journal of Clinical Practice
|
November 26, 2009
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
K G Parhofer, K I Birkeland, R DeFronzo, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
November 25, 2003
[Integrin Beta 3 PlA1/PlA2 polimorphism does not contribute to complications in both type 1 and type 2 diabetes]
L Pucci, D Lucchesi, C Fotino, et al.
Metabolism: Clinical and Experimental
|
June 1, 1981
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle
R Nosadini, K G Alberti, D G Johnston, et al.
European Journal of Clinical Investigation
|
January 5, 2000
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR)
S E Baldeweg, A Golay, A Natali, et al.
The Journal of Clinical Investigation
|
July 1, 1996
Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals
A Avogaro, G Toffolo, M Miola, et al.
Diabetes/Metabolism Reviews
|
September 1, 1995
Metformin and free fatty acid metabolism
S Del Prato, S Marchetto, A Pipitone, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1996
Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism
A Avogaro, A Valerio, M Miola, et al.
Metabolism: Clinical and Experimental
|
May 1, 1983
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects
A Avogaro, E Duner, C Marescotti, et al.
Expert Review of Clinical Pharmacology
|
April 23, 2017
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus
A Avogaro, A Giaccari, P Fioretto, et al.
Metabolism: Clinical and Experimental
|
May 1, 1990
Obesity and insulin resistance in humans: a dose-response study
R C Bonadonna, L Groop, N Kraemer, et al.
Page
of 21